IBA Announces First Completed Treatment with Proton Therapy Specific Cone Beam CT

December 29, 2014 — IBA (Ion Beam Applications SA) and Université Catholique de Louvain announced that the first patient treatment with IBA's Proton Therapy Specific Cone Beam CT (CBCT) was successfully completed at Penn Medicine's Roberts Proton Therapy Center.

As a component of IBA's image guided proton therapy (IGPT) solution, CBCT provides 3-D imaging for increased accuracy in patient treatment. It is fully integrated with IBA's imaging platform adaPTinsight, developed in partnership with the Université catholique de Louvain (UCL), to offer fast 6-D corrections of patient positioning for IBA's Proteus PLUS and Proteus ONE proton therapy solutions.

For more information: www.iba-worldwide.com